| Robert Kiesel, MD | |
|
400 N 17th St, Suite 200, Allentown, PA 18104 | |
| (610) 433-2021 | |
| (610) 433-7856 |
| Full Name | Robert Kiesel |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 63 Years |
| Location | 400 N 17th St, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174600399 | NPI | - | NPPES |
| 015861 | Other | PA | BLUE SHIELD |
| 50025517 | Other | PA | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD007162E (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Harry W Buchanan Iv Md | 0244221794 | 2 |
News Archive
Nine months into the COVID-19 pandemic, scientists are still seeking to understand the protective immunity that develops against the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite the increasing need for serological tests in epidemiology, their clinical value has not been fully established. A new paper published in the Journal of Medical Virology in September 2020 describes the relationship of COVID-19 disease symptoms with the serological status over time.
In a development that could lead to a new generation of drugs to precisely treat a range of diseases, scientists from the Florida campus of The Scripps Research Institute have for the first time designed a drug candidate that decreases the growth of tumor cells in animal models in one of the hardest to treat cancers—triple negative breast cancer.
A team of researchers from the Federal University of Health Sciences of Porto Alegre and the Federal University of Rio Grande do Sul performed a systematic review to assess these population-based COVID-19 prevalence surveys' reliability and biases qualitatively. Their study is published on the preprint server medRxiv.
ULURU Inc. (NYSE Alternext: ULU) today announced that Gregory Bohn, M.D., FACS, Medical Director, Trinity Wound Care and Hyperbaric Medicine, Bettendorf, Iowa, has presented nine clinical posters at the 24th Annual "Clinical Symposium on Advances in Skin and Wound Care" being held in San Antonio, Texas.
› Verified 2 days ago
| Entity Name | Harry W Buchanan Iv Md |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174668768 PECOS PAC ID: 0244221794 Enrollment ID: O20040521001264 |
News Archive
Nine months into the COVID-19 pandemic, scientists are still seeking to understand the protective immunity that develops against the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite the increasing need for serological tests in epidemiology, their clinical value has not been fully established. A new paper published in the Journal of Medical Virology in September 2020 describes the relationship of COVID-19 disease symptoms with the serological status over time.
In a development that could lead to a new generation of drugs to precisely treat a range of diseases, scientists from the Florida campus of The Scripps Research Institute have for the first time designed a drug candidate that decreases the growth of tumor cells in animal models in one of the hardest to treat cancers—triple negative breast cancer.
A team of researchers from the Federal University of Health Sciences of Porto Alegre and the Federal University of Rio Grande do Sul performed a systematic review to assess these population-based COVID-19 prevalence surveys' reliability and biases qualitatively. Their study is published on the preprint server medRxiv.
ULURU Inc. (NYSE Alternext: ULU) today announced that Gregory Bohn, M.D., FACS, Medical Director, Trinity Wound Care and Hyperbaric Medicine, Bettendorf, Iowa, has presented nine clinical posters at the 24th Annual "Clinical Symposium on Advances in Skin and Wound Care" being held in San Antonio, Texas.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Kiesel, MD 400 N 17th Street, Suite 200, Allentown, PA 18104 Ph: (610) 433-2021 | Robert Kiesel, MD 400 N 17th St, Suite 200, Allentown, PA 18104 Ph: (610) 433-2021 |
News Archive
Nine months into the COVID-19 pandemic, scientists are still seeking to understand the protective immunity that develops against the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Despite the increasing need for serological tests in epidemiology, their clinical value has not been fully established. A new paper published in the Journal of Medical Virology in September 2020 describes the relationship of COVID-19 disease symptoms with the serological status over time.
In a development that could lead to a new generation of drugs to precisely treat a range of diseases, scientists from the Florida campus of The Scripps Research Institute have for the first time designed a drug candidate that decreases the growth of tumor cells in animal models in one of the hardest to treat cancers—triple negative breast cancer.
A team of researchers from the Federal University of Health Sciences of Porto Alegre and the Federal University of Rio Grande do Sul performed a systematic review to assess these population-based COVID-19 prevalence surveys' reliability and biases qualitatively. Their study is published on the preprint server medRxiv.
ULURU Inc. (NYSE Alternext: ULU) today announced that Gregory Bohn, M.D., FACS, Medical Director, Trinity Wound Care and Hyperbaric Medicine, Bettendorf, Iowa, has presented nine clinical posters at the 24th Annual "Clinical Symposium on Advances in Skin and Wound Care" being held in San Antonio, Texas.
› Verified 2 days ago
Irene Cherfas Tsyvine, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1739 W Fairmont St, Allentown, PA 18104 Phone: 610-437-4988 | |
William Michael Mclaughlin Jr., DO Ophthalmology Medicare: Medicare Enrolled Practice Location: 1251 S Cedar Crest Blvd, Suite 307, Allentown, PA 18103 Phone: 610-820-6320 Fax: 610-820-8376 | |
Lisa S Bunin, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1611 Pond Rd, Ste 403, Allentown, PA 18104 Phone: 610-435-5333 Fax: 610-435-2253 | |
Alan D Listhaus, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 400 N 17th St, Ste 101, Allentown, PA 18104 Phone: 610-433-0450 Fax: 610-433-4655 | |
Dr. Avani Shah, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 401 N 17th St, Ste 103, Allentown, PA 18104 Phone: 610-969-3070 Fax: 610-969-3073 | |
David A De Rose, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1251 South Cedar Crest Blvd, Suite 307, Allentown, PA 18103 Phone: 610-820-6320 Fax: 610-820-8376 |